Literature DB >> 25429069

MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.

Jeremy J Racine1, Mingfeng Zhang2, Miao Wang2, William Morales3, Christine Shen3, Defu Zeng4.   

Abstract

Type 1 diabetic NOD mice have defects in both thymic negative selection and peripheral regulation of autoreactive T cells, and induction of mixed chimerism can effectively reverse these defects. Our recent studies suggest that MHC-mismatched mixed chimerism mediates negative selection of autoreactive thymocytes in wild-type NOD and TCR-transgenic NOD.Rag1(+/+).BDC2.5 mice. However, it remains unknown how mismatched I-A(b) MHC class II can mediate deletion of autoreactive T cells positively selected by I-A(g7). In the present study, we directly tested the hypothesis that mismatched MHC class II in mixed chimeras mediates deletion of cross-reactive autoreactive thymocytes. We first identify that transgenic BDC2.5 T cells from NOD.Rag1(+/+).BDC2.5 but not NOD.Rag1(-/-).BDC2.5 mice possess cross-reactive TCRs with endogenous TCRα-chains; MHC-mismatched H-2(b) but not matched H-2(g7) mixed chimerism mediates thymic deletion of the cross-reactive transgenic T cells in NOD.Rag1(+/+).BDC2.5 mice. Second, by transplanting T cell-depleted (TCD) bone marrow (BM) cells from NOD.Rag1(+/+).BDC2.5 or NOD.Rag1(-/-).BDC2.5 mice into lethally irradiated MHC-mismatched H-2(b) C57BL/6 or MHC-matched congenic B6.H-2(g7) recipients, we demonstrate that NOD.Rag1(+/+).BDC2.5 BM-derived cross-reactive transgenic T cells, but not NOD.Rag1(-/-).BDC2.5 BM-derived non-cross-reactive transgenic T cells, can be positively selected in MHC-mismatched H-2(b) thymus. Third, by cotransplanting NOD.Rag1(+/+).BDC2.5 TCD BM cells with BM cells from MHC-mismatched T cell-deficient C57BL/6 mice into lethally irradiated MHC-matched B6.H-2(g7) recipients, we demonstrate that thymic deletion of the cross-reactive transgenic T cells is dependent on MHC-mismatched donor BM-derived APCs but not on donor BM-derived T cells. Taken together, our studies indicate that MHC-mismatched mixed chimerism can mediate thymic deletion of cross-reactive autoreactive T cells that express more than one TCR.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25429069     DOI: 10.4049/jimmunol.1401584

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.

Authors:  Limin Wu; Nainong Li; Mingfeng Zhang; Sheng-Li Xue; Kaniel Cassady; Qing Lin; Arthur D Riggs; Defu Zeng
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-08       Impact factor: 11.205

2.  Haploidentical mixed chimerism cures autoimmunity in established type 1 diabetic mice.

Authors:  Yuqing Liu; Xiaoqi Wang; Yongping Zhu; Mingfeng Zhang; Ubaydah Nasri; Sharne S Sun; Stephen J Forman; Arthur D Riggs; Xi Zhang; Defu Zeng
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

3.  MHC-mismatched mixed chimerism restores peripheral tolerance of noncross-reactive autoreactive T cells in NOD mice.

Authors:  Mingfeng Zhang; Jeremy J Racine; Qing Lin; Yuqing Liu; Shanshan Tang; Qi Qin; Tong Qi; Arthur D Riggs; Defu Zeng
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

4.  Altered Macrophage and Dendritic Cell Response in Mif-/- Mice Reveals a Role of Mif for Inflammatory-Th1 Response in Type 1 Diabetes.

Authors:  Yuriko Itzel Sánchez-Zamora; Imelda Juarez-Avelar; Alicia Vazquez-Mendoza; Marcia Hiriart; Miriam Rodriguez-Sosa
Journal:  J Diabetes Res       Date:  2016-09-06       Impact factor: 4.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.